Studies
-
Implementation
endTB (Expand New Drugs for TB) Observational Study: Treatment of MDR-TB with regimens containing bedaquiline or delamanid
Study details: Observational study in Armenia , Bangladesh , Belarus , Ethiopia , Georgia , Indonesia , Kazakhstan , Kenya , Kyrgyzstan , Lesotho , Myanmar , Nepal , Pakistan , Peru , South AfricaPrincipal investigator: Helena HuergaLatest update:Completed date changed by Helena Huerga| 9th December 2022